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1. Introduction
Previously, osteoporosis was diagnosed as an absolute decrease in the amount of bone and
fracture after minimal trauma[1]. The disadvantage with this definition is patients already
have fractures and osteoporosis is sufficiently advanced for it to be visualized on the plain X-
ray. The National Institute of Health (NIH) has redefined osteoporosis as a skeletal disorder
characterized by compromised bone strength that increases the risk of fracture2. Bone strength
primarily reflects the integration of bone density and bone quality. Bone quality refers to
architecture, turnover, damage accumulation and mineralization. Currently there is no
accurate measure of the overall bone quality. The ability to precisely measure bone mineral
density (BMD) has only become available in the past few decades and accounts for approxi‐
mately 70% of bone strength [3,4].
2. Bone densitometry
Traditional X-rays cannot measure bone density, however, they may provide suggestive
evidence of osteoporosis. However, this is not accurate and BMD must be decreased by
approximately 50% to be appreciated on a plain X-ray. Moreover, radiologist subjective
assessments are not always correct. Therefore, routine X-rays are not intended to assess BMD
and an apparently normal appearance cannot exclude osteoporosis.[5] Dual-energy X-ray
absorptiometry (DXA, previously DEXA[6, 7]), designed to determine bone minerals in central
sites such as lumbar spine and the hip, is of greater relevance to clinical osteoporosis. Some‐
times forearm measurements can also be made, but they are not routine. Central DXA
examinations have three major roles, namely the diagnosis of osteoporosis, the assessment of
patients' risk of fracture, and monitoring the response to treatment. Different centres use
different machines with different software that make it imperative to perform the follow up
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on the same machine. Usually, DXA gives a precise and accurate measurement of BMD, but
under certain conditions this may lead to an over or under estimation[8] (Table1).











Table 1. Pitfalls in Measurements of Bone Mineral Density.
3. Diagnosis of osteoporosis
The DXA report provides the bone mineral content in a given area of bone. This gives a BMD
in grams per square centimetre (g/cm2). However, The BMD values in (g/cm2) are not used for
diagnosing osteoporosis. Instead, a working group of the World Health Organization (WHO)
proposed defining osteoporosis on the basis of the T-score measured by the central DXA at the
lumbar spine, total hip or femoral neck (or 1/3 radius if the lumber spine or hip cannot be
measured) in a postmenopausal woman and men 50 years and older. A BMD T-score that is
2.5 standard deviation or more below the young-adult mean BMD is defined as osteoporosis,
provided that the other causes of low BMD have been excluded (such as osteomalacia). (Table2)
Category Bone mass
Normal A value for BMD within 1 SD of the young adult female reference mean (T-score at-1.0 and above)
Low bone mass
“Osteopenia”
A value for BMD of more than 1 but less than 2.5 SD below the young adult female
reference mean (T-score between -1.0 and -2.5)
Osteoporosis A value for BMD of 2.5 or more SD below the young adult female reference mean (T-score at or below -2.5)
Severe (established)
osteoporosis
A value for BMD of 2.5 or more SD below the young adult female reference mean in
the presence of one or more fragility fractures
Table 2. Diagnostic categories for osteoporosis and low bone mass based upon bone mineral density measurements by
DXA.
The WHO group also described a second diagnostic category, which was termed “osteopenia”
defined as a T-score between-1.0 and-2.5 standard deviation. Experts are moving away from
the term osteopenia and instead simply labelling it as low bone density. However, there are
more fractures in this range because there are so many more patients in this category.
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A T-score calculated using the formula: (patient's BMD − young normal mean)/SD of young
normal (same gender and ethnicity). For example, if a patient has a BMD of 0.700 (g/cm2), the
young normal mean is 1.000(g/cm2), and the young normal SD is 0.100 (g/cm2), then this
patient's T-score would be (0.700−1.000)/0.100, or −0.300/0.100, or −3.0. A T-score of 0 is equal
to the young normal mean value, −1.0 is 1 SD low, and −3.0 is 3 SD low[8]. Usually, 1 SD is
equal to 10 to 15 percent of the BMD value in (g/cm2). In addition to the T-scores, DXA reports
also provide Z-scores, which are calculated similarly to the T-score, except that the patient's
BMD is compared with an age-matched (race and gender-matched) mean, and the result is
expressed as an SD score. Since bone density declines with age, using the Z score for a diagnosis
would suggest that the prevalence of osteoporosis does not increase with age.
The WHO classification should not applied to healthy premenopausal women, men less than
50 years of age and children. In these groups, Osteoporosis cannot be diagnosed on the basis
of densitometric criteria alone. The international society for clinical densitometry (ISCD)
recommends using the Z-scores rather than T-scores. A Z-score of-2.0 or lower is defined as
“below the expected range for age” and a Z-score above-2.0 is “within the expected range for
age” [9].
Although not part of the WHO classification, a clinical osteoporosis, regardless of T-score,
should be considered in the presence of a fragility fracture (that occurs as a result of a minimal
trauma, such as a fall from a standing height or less, or no identifiable trauma) particularly at
the spine, proximal femur (hip), distal forearm (wrist) and proximal hummers. Provided other
causes for fractures have been excluded, such as a motor vehicle accident, pathological
fractures and stress fractures. Certain skeletal locations, including the skull, cervical spine, feet
and hands are not associated with fragility fractures [7,10].
4. Site of measurement of BMD
The international society for clinical densitometry (ISCD) recommends obtaining BMD
measurements of the posteroanterior spine and hip (right or left) in very obese patients, those
with primary hyperparathyroidism, or those in whom the hip or the spine, or both, cannot be
measured or interpreted such as with degenerative arthritis, prior vertebral fractures, verte‐
broplasty and total hip arthroplasty, BMD may be measured in the forearm, using a 33% radius
on the nondominant forearm by DXA or peripheral DXA[9], otherwise non-central DXA bone
mass measurement devices cannot be used for the diagnosis using the WHO classification.
However, it may be used to assess fracture risk.
5. Conclusion
Osteoporosis can be diagnosed clinically or radiographically by DXA. BMD assessment by a
central DXA scan of the total hip, femoral neck, or lumbar spine is the standard test to diagnose
osteoporosis in a postmenopausal woman or men over age 50, based on the WHO classifica‐
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tion. A BMD T-score of 2.5 or more below the young-adult mean BMD is defined as osteopo‐
rosis. It is appropriate to consider a clinical diagnosis of osteoporosis in individuals who have
sustained fragility fracture(s) even if BMD is not in the osteoporotic range, as the majority of
fractures occur in those who have a T-score above-2.5. The WHO classification should not be
applied to premenopausal women and men less than 50 years of age and children. Z–scores,
not T-scores are preferred. A Z-score of-2.0 or lower is defined as “below the expected range
for age”. However, in these groups osteoporosis cannot be diagnosed on densitometric criteria
alone[9].
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